Company
Epirium Bio
Epirium Bio is a biopharmaceutical company that has identified and established an IP-protected platform of orally bioavailable small molecules that leverages the potential of PGE-2 signaling to restore tissue homeostasis, resolving aberrant inflammation, stimulating regeneration, and reducing fibro…
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- San Diego, California, United States
- Founded
- 2008
Record updated 28 September 2026
About
Epirium Bio is a biopharmaceutical company that has identified and established an IP-protected platform of orally bioavailable small molecules that leverages the potential of PGE-2 signaling to restore tissue homeostasis, resolving aberrant inflammation, stimulating regeneration, and reducing fibrosis. Our oral therapies have the potential to improve function in neuromuscular diseases including sarcopenia, inflammatory and fibrotic diseases.